HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mélanie Gadelorge Selected Research

Immunotherapy

3/2009A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mélanie Gadelorge Research Topics

Disease

3Multiple Myeloma
01/2022 - 03/2012
1Hyperparathyroidism
05/2012
1Bone Resorption
05/2012
1B-Cell Lymphoma (Lymphoma, B Cell)
03/2009
1Neoplasms (Cancer)
03/2009

Drug/Important Bio-Agent (IBA)

1Toll-Like Receptor 4IBA
01/2022
1collagen type I trimeric cross-linked peptideIBA
05/2012
1MineralsIBA
05/2012
1Collagen Type I (Type I Collagen)IBA
05/2012
1Lenalidomide (CC 5013)FDA Link
03/2012
1Bortezomib (Velcade)FDA Link
03/2012
1Melphalan (Alkeran)FDA LinkGeneric
03/2012
1Growth Differentiation Factor 15IBA
03/2012
1Peptides (Polypeptides)IBA
03/2009
1CytokinesIBA
03/2009

Therapy/Procedure

1Drug Therapy (Chemotherapy)
05/2012
1Stem Cell Transplantation
05/2012
1Immunotherapy
03/2009